BPC-157
COA published
A synthetic pentadecapeptide studied in in-vitro models of tissue-repair signalling and cellular migration.
From$54.00Select size
DSIP
CAS62568-57-4
A delta sleep-inducing peptide studied in sleep-architecture and neuroendocrine research.
- Test methods
- HPLC-UV + LC-MS
- Purity target
- 99%+ verified
- Sizes available
- 1
- Availability
- In stock
Select size
Quantity
1
Total
$42.00
That's the price. No inflated list, no permanent “discount” code to make it look cheaper than it is.
Certificate for this lot is pending. Every batch we ship is published at /coa before it goes out.
For Research Use Only. Not for Human Consumption.
Products supplied by Synthrex Biotech LLC are intended strictly for in-vitro laboratory research and development by qualified professionals. They are not drugs, foods, cosmetics, or dietary supplements, and are not approved by the FDA for human or veterinary use. They are not sold for, and must not be used for, human or animal consumption or administration of any kind. Synthrex Biotech LLC is not a compounding pharmacy or chemical compounding facility as defined under section 503A of the Federal Food, Drug, and Cosmetic Act, and is not an outsourcing facility as defined under section 503B of that Act. By purchasing, you affirm that you are a qualified researcher acquiring these materials for lawful research purposes only. A Safety Data Sheet (SDS/MSDS) is available on request for every compound.
Sold by Synthrex Biotech LLC. A Safety Data Sheet (SDS) is available on request at support@synthrexbiotech.com.
✦ Research Notes
Background & literature
Origin
Delta sleep-inducing peptide is a nonapeptide isolated in 1977 by Guido Schoenenberger and Marcel Monnier in Switzerland, from the cerebral venous blood of rabbits in an induced sleep state. The isolation method is the memorable part: they transfused blood from sleeping animals into recipients and looked for a transferable factor. The peptide has proven durably mysterious — a 2006 review in the Journal of Neurochemistry is titled, accurately, “a still unresolved riddle.”
What has been characterised
Despite nearly fifty years of study, no receptor for DSIP has been identified, and its endogenous function is not established. Published work describes effects observed in various animal models, but without a characterised receptor or a reproducible mechanism the literature remains inconclusive — which is what the “unresolved riddle” framing refers to. We would rather tell you that than manufacture a mechanism. Not FDA-approved for any use.
Sources
- 1.“Delta sleep-inducing peptide (DSIP): a still unresolved riddle.” J Neurochem, 2006. PMID 16539679
- 2.“Delta sleep-inducing peptide.” Eur J Anaesthesiol, 2001. PMID 11437870
These notes are provided for scientific context only. They describe published laboratory and preclinical research and are not a claim of any effect in humans. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Batch releases & restocks
Know when the next batch is tested
We publish an independent certificate for every lot before it ships. Join the Lab List and we'll tell you when a new one lands and when a sold-out compound is back — plus 15% off your first order, shown on screen the second you join.
Batch and restock notices from Synthrex Biotech LLC. No dosing advice, ever. One-click unsubscribe on every email.
Related Compounds
TB-500
COA published
A thymosin beta-4 fragment investigated in research on cellular migration and angiogenesis pathways.
$50.00View
BPC-157 + TB-500 Blend
COA published
A combined preparation of BPC-157 and TB-500 used in comparative tissue-repair research models.
From$90.00Select size
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.